Nowadays, we hardly ever remember when the pandemic really started, and we’re so used to it that almost hurts. Yet desperate in the beginning, we soon came to a solution able to fight COVID-19 and provide long-term protection. And that’s when the COVID-19 vaccines came in to help.
As 4 approved in the EU and 3 in the U.S., they prevented many COVID-19 cases and saved lives. But the process of massive vaccination didn’t always go smoothly and was often surrounded by questions and suspicions. After AstraZeneca’s vaccine was compromised with possible links to blood clots, Jannsen COVID-19 vaccine seemed to issue the same concerns, too.
The Janssen COVID-19 vaccine was authorised for emergency use on 27th February by the FDA for adults above 18 years. Out of 120 million population, 7 million Americans got their dose, 9 got blood clots and 1 of them died.
For the EU it was authorised on 11th March, followed by WHO on the next day, concerning emergency use and COVAX rollout. However, due to the ongoing circumstances, the Jannsen COVID-19 vaccine was never able to go widespread in the EU.
It eventually caused the FDA immediate response for the U.S. to pause the vaccination with the Jannsen COVID-19 vaccine, ‘out of an abundance’ of caution. Although the cases are extremely rare, the vaccine safety is questionable and brings people to decline the Jannsen COVID-19 vaccine. People who already got inoculated are doubtful what to expect and are just counting on time they won’t get the symptoms.
There are a few more things about the investigated cases we also have to take in mind. All nine of the women were known to previously had suffered cerebral venous sinus thrombosis and had low platelet counts. The Jannsen COVID-19 vaccine somehow activated platelets and led to clots that route blood away from the brain. However, the anticoagilant drug heparine is dangerous and can’t be administered as a treatment.
One woman who suffered a clot was using oral birth control medication, according to Anne Schuchat, principal deputy director of the CDC. As it turns out, estrogen-containing oral contraceptives are associated with a risk of blood clots. However, Krishna Upadhya, a vice president of quality care and health equity for Planned Parenthood Federation of America, disagreed. As both things aren’t necessarily associated, women receiving Jannsen COVID-19 vaccine who take hormonal contraceptive pills should continue using it.
Obviously, not every woman between 18 and 48 who got the Jannsen COVID-19 vaccine has to worry or overreact. Patients who develop COVID and get hospitalized are at a much higher risk than the one following a COVID-19 vaccine. What’s more disturbing is how two-shots of Pfizer and Moderna vaccines are going to substitute halting of Jannsen COVID-19 vaccine.
This is a devastating blow to this J&J vaccine effort in the United States
Dr. Kavita Patel, a primary care physician in Washington urged.
The blood clots identified after the AstraZeneca and Jannsen COVID-19 vaccine are concerning, but appear to be quite rare. Mortality and morbidity rates can be only decreased if we understand the benefits outweigh the risks, and we should act RIGHT NOW. At the end, it all depends on us – our choices, our health, our lives.
MVS Pharma GmbH is an innovative pharmaceutical start-up company, which researches in the area of reducing viruses and bacteria with plant based aerosols. Their special formula ensures the purity and the stability of the used ingredients during storage.
Liliya Ganeva is an article writer, who explores all the actual, up-to-date COVID-19 information, and the possibilities for producing aerosols made out of plants against respiratory viruses and bacteria.